Sacred Lotus Médecine Chinoise et Intégrative

Relationship Graph

Sacred Lotus connections

Updated
Sep 2026

Drug: GHK-Cu (peptide de cuivre)

My Plan

Le GHK-Cu est un petit peptide fixateur de cuivre : les acides aminés glycine, histidine et lysine reliés en chaîne, retenant un ion cuivre. Il est présent naturellement dans le sang et la peau, et son taux diminue avec l'âge. Sur la peau, il est vendu dans des sérums et des crèmes pour la fermeté, les ridules et la réparation. Le dossier repose surtout sur des travaux de laboratoire et animaux : dans des cellules cutanées en culture, le GHK-Cu augmente le collagène, et dans des plaies animales il accélère la construction de la matrice.

Les données humaines sont minces. Le seul essai facial randomisé, chez des personnes en cicatrisation après un resurfaçage au laser, n'a trouvé aucun bénéfice mesuré sur les rides ou les rougeurs, même si ces patients jugeaient leur propre peau meilleure. Appliqué sur une peau intacte, il est généralement bien toléré. L'usage injecté ou systémique n'est pas testé.

Cost
Low to MidLow to Mid · Serum you apply yourself · easy daily use · firmness claims play out over weeks to months
Effort
EasyEasy
Results In
Weeks to MonthsWeeks to Months

Findings & Outcomes

Preliminary

What It Is

GHK-Cu is a copper-binding tripeptide: three amino acids, glycine, histidine and lysine, linked in a short chain that grips a single copper ion. The peptide part, GHK, is made in the body and circulates in blood, saliva and urine. In plasma it runs around 200 nanograms per milliliter in young adults and drops by roughly two thirds by age sixty. It binds copper tightly, and the copper-loaded form is what most of the research studies.

In skin care it appears in serums, creams and eye products under names like copper tripeptide-1 and GHK-Cu, usually at a fraction of a percent. It is marketed for firmer skin, softer fine lines, and faster repair after irritation or a cosmetic procedure. Weaker cosmetic relatives exist, including a copper complex of the peptide AHK. Applied to the skin, GHK-Cu is a cosmetic ingredient with a mechanism worth taking seriously and a small, mixed human record.

What It Does

In cultured skin cells GHK-Cu raises the output of collagen and other components of the tissue scaffold, and it supports the fibroblasts that build that scaffold. In animals the signal is repair. Injected into wound chambers under the skin of rats, GHK-Cu produced a dose-dependent rise in collagen, protein, DNA and glycosaminoglycan content. Collagen synthesis climbed about twice as fast as other proteins. A biotinylated form of the peptide, carried in a collagen dressing, sped wound contraction and matrix buildup in diabetic rats. Not every animal result agrees. One guinea-pig study of the same complex found slower skin reorganization and delayed fibroblast activation alongside the rise in collagen expression.

The human evidence is where the popular claims outrun the data. The one randomized, blinded facial trial gave GHK-Cu skin-care products or the same routine without the peptide to thirteen patients healing from carbon-dioxide laser resurfacing. Blinded raters and computer analysis found no advantage in clearing redness, and no measured improvement in wrinkles or overall skin quality. The only edge was that patients using GHK-Cu rated their own skin higher on a questionnaire. Larger cosmetic-firmness studies appear in marketing material, but they are mostly industry documents that never reached peer review.

Much of the most confident writing on GHK-Cu comes from the scientist who discovered the peptide and founded the company that sells it. Several of the widely cited review papers share that authorship. Lean on the raw cell and animal data, and treat the strongest claims with care.

The evidence for hair is the weakest. The follicle study most often cited in support tested AHK-Cu, a related copper tripeptide, not GHK-Cu itself. It lengthened human hair follicles and helped dermal papilla cells in the dish. Direct evidence that topical GHK-Cu grows hair in people is lacking.

The Research & Studies

Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.

How it works

GHK-Cu stimulates collagen and matrix synthesis in cultured skin fibroblastsEmerging
In plain terms

In lab dishes, GHK-Cu prompts skin cells to make more collagen and other building blocks of firm skin.

In detail

In cultured human skin fibroblasts, the tripeptide-copper complex GHK-Cu increased collagen synthesis, an effect first reported by Maquart and colleagues and repeatedly described since. GHK-Cu also raises production of elastin and glycosaminoglycans and supports fibroblast function, and copper is a required cofactor for lysyl oxidase, the enzyme that cross-links collagen and elastin into firm tissue. Measured in: Cultured human dermal fibroblasts. This is cell-culture work; a mechanism shown in a dish does not establish that a topical serum produces a visible change in a person's skin.

The studies · 2

Maquart et al., Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex GHK-Cu · FEBS Lett 1988;238(2):343-346

Pickart et al., GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration · Biomed Res Int 2015;2015:648108

GHK binds a reactive lipid-breakdown product in vitro, a modest antioxidant actionPreliminary
In plain terms

In a test tube, GHK mops up a damaging molecule made when skin fats break down, though it does this more weakly than carnosine.

In detail

In physiological buffer, the tripeptide GHK quenched the cytotoxic lipid-peroxidation product 4-hydroxy-2-nonenal (HNE) by forming a GHK-HNE adduct, confirmed by mass spectrometry and NMR, but it was significantly less potent than the reference antioxidant peptide carnosine. Reviews of gene-expression data describe GHK influencing a broad set of repair, antioxidant and inflammation-related pathways. Measured in: Cell-free physiological buffer assays and gene-expression reviews. This is a test-tube chemistry result and gene-expression review, not a measured antioxidant benefit in human skin; the effect was weaker than the comparator.

The studies · 2

Beretta et al., Glycyl-histidyl-lysine (GHK) is a quencher of alpha,beta-4-hydroxy-trans-2-nonenal · Chem Res Toxicol 2007;20(9):1309-1314

Pickart et al., The human tri-peptide GHK and tissue remodeling · J Biomater Sci Polym Ed 2008;19(8):969-988

Skin And Hair

GHK-Cu increased connective-tissue and collagen accumulation and sped wound repair in animal modelsPreliminary
In plain terms

Chez le rat, le GHK-Cu appliqué sur des plaies a entraîné une accumulation accrue de collagène et de tissu de réparation et, dans un modèle de rat diabétique, a fermé les plaies plus rapidement que l'absence de traitement.

In detail

Dans des chambres de plaies sous-cutanées chez le rat, l'injection séquentielle de GHK-Cu a produit une augmentation dose-dépendante du poids sec, de l'ADN, des protéines totales, du collagène et de la teneur en glycosaminoglycanes, la synthèse de collagène étant stimulée environ deux fois plus que celle des protéines non collagéniques, et l'ARNm des collagènes de type I et III étant augmenté, tandis qu'un tripeptide témoin inactif n'a eu aucun effet. Chez des rats rendus diabétiques par streptozotocine, un peptide GHK biotinylé véhiculé dans une matrice de collagène a augmenté la vitesse de contraction de la plaie et a élevé le collagène, les protéines et l'ADN dans le tissu de granulation par rapport aux témoins non traités et au collagène seul. Measured in: Rat subcutaneous wound chambers and streptozotocin-induced diabetic rat skin wounds. These are animal wound models, not human trials; one guinea-pig study of the same complex found slower skin reorganization and delayed fibroblast activation, so the repair effect in living tissue is not uniform.

The studies · 2

Maquart et al., In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex GHK-Cu in rat experimental wounds · J Clin Invest 1993;92(5):2368-2376

Arul et al., A therapeutic approach for diabetic wound healing using biotinylated GHK incorporated collagen matrices · Life Sci 2007;80(4):275-284

Topical GHK-Cu did not improve measured wrinkles or redness after laser resurfacing, though patients rated their skin higherPreliminary · no effect
In plain terms

In the one randomized facial trial, people healing from laser resurfacing who used GHK-Cu products saw no measured improvement in wrinkles or redness over the same routine without it, though they rated their own skin as better.

In detail

In a randomized trial, 13 patients healing from circumoral carbon-dioxide laser resurfacing used a post-treatment regimen with or without GHK-Cu skin-care products. Blinded evaluators and computer analysis found no statistically significant difference between groups in the resolution of erythema, and no significant improvement in wrinkles or overall skin quality at 12 weeks. Patient-reported satisfaction with overall skin quality was higher in the GHK-Cu group (P = 0.04). Measured in: 13 adults completing a post-CO2-laser-resurfacing regimen. The trial was very small at 13 completers and tested products on freshly resurfaced skin, not routine aging, so it neither confirms nor rules out a cosmetic benefit; the only positive was subjective patient rating.

The study · 1

Miller et al., Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin · Arch Facial Plast Surg 2006;8(4):252-259

A related copper tripeptide lengthened human hair follicles in the lab; direct GHK-Cu hair evidence in people is lackingPreliminary · mixed
In plain terms

A cousin copper peptide made human hair follicles grow longer in the lab, but this was not GHK-Cu, and no good study shows GHK-Cu grows hair in people.

In detail

The copper tripeptide AHK-Cu (L-alanyl-L-histidyl-L-lysine-Cu) stimulated elongation of human hair follicles ex vivo and the proliferation of cultured dermal papilla cells at picomolar-to-nanomolar concentrations, and shifted apoptosis markers in papilla cells. The study tested AHK-Cu, a relative of GHK-Cu, not GHK-Cu itself, and there is no controlled trial showing topical GHK-Cu grows hair in people. Measured in: Excised human hair follicles and cultured human dermal papilla cells. The follicle study used AHK-Cu, not GHK-Cu, was done on excised follicles and cultured cells, and does not establish a hair-growth effect from a GHK-Cu product on a person.

The study · 1

Pyo et al., The effect of tripeptide-copper complex on human hair growth in vitro · Arch Pharm Res 2007;30(7):834-839

How It Works

Copper is a required cofactor for lysyl oxidase, the enzyme that cross-links collagen and elastin into firm tissue. GHK carries copper into cells in a usable form. The second proposed mechanism is signaling. GHK, with or without copper, changes the genes skin cells express. It raises synthesis of collagen, elastin and glycosaminoglycans, supports fibroblasts, and in gene-expression reviews touches a broad set of repair and inflammation pathways. GHK also acts as a modest antioxidant, binding the reactive lipid-breakdown product 4-hydroxynonenal in a test tube, though less strongly than carnosine.

GHK-Cu is not an exfoliant that works on the surface. It supplies copper and signals to the cells underneath to make more collagen and matrix. That is why any visible change is slow, and why we understand how it works better than we can show that it works in people.

Anatomy of the Practice

1In the first days

On intact skin a serum delivers the peptide and its copper into the upper layers. Nothing visible happens quickly. In wounded or freshly resurfaced tissue the cell work matters most, and the animal data show matrix proteins starting to accumulate within days.

2Over weeks

The proposed benefit is a gradual rise in collagen and other scaffold material as fibroblasts respond, the same slow rebuilding that any collagen-directed treatment depends on. This is the window the cosmetic products are used across, though few controlled trials have measured what happens over it.

3The ceiling

GHK-Cu supplies a cofactor and a signal. It does not replace the treatments proven to slow skin aging, and at best adds a small amount on top of what those already do.

How to Use It

Ways to Do It

The practices with the strongest human evidence for skin cost little or nothing, and they come first. A copper-peptide serum layers on top of those basics. Start at the first rung.

1
Cover the proven basics firstFree to $Easy

Daily broad-spectrum sunscreen, not smoking, and sleep do more for skin firmness and fine lines than any peptide, and they are free or nearly so. A prescription or over-the-counter retinoid has the strongest human evidence of any topical for sun-aged skin. If you do only one thing, it is sunscreen, and if you add one active, a retinoid has more behind it than a copper peptide.

2
Add a copper-peptide serum$ to $$Easy

A GHK-Cu or copper tripeptide-1 serum, applied to clean skin once or twice a day, is the ordinary way to use it. Introduce it on its own for a week or two to check your skin tolerates it before layering it with other actives. Judge it over months, not weeks; the human trials are few and small.

3
Fit it into a routine$ to $$Moderate

If you want to combine it with a retinoid, use them at different times of day. Low pH and strong oxidizers can pull copper off the peptide, and some retinoid formulas are acidic. Patch test any new pairing. The ingredient is used at low percentages, and higher concentrations have not been shown to do more.

Go Deeper

  • Tretinoin: the topical with the strongest human evidence for sun-aged skin and acne, the one to reach for before a copper peptide.
  • Skin and hair: the goal page that gathers what actually moves skin firmness, texture and hair, ranked by how strong the evidence is.
  • Collagen supplements: the other collagen-branded product, with its own small and mostly industry-funded human record.
  • Vitamin C: the topical antioxidant most often paired with sunscreen, with a longer research trail than copper peptides.
  • BPC-157: the injected healing peptide sold on the same recovery promise, where rodent research runs well ahead of any human trial.

The Chinese Medicine View

Chinese medicine has no counterpart to a synthetic copper peptide. The tradition treats skin from the inside. It reads dullness, dryness and slow healing through patterns such as Blood deficiency, Blood dryness, or a weak Spleen failing to nourish the flesh. It works through diet, herbs and lifestyle, and expects no topical to reprogram skin cells.

The tradition and the peptide share only a cautious stance; their mechanisms do not overlap. A practitioner reading a person as Blood deficient, with dry skin and thin, slow-growing hair, would treat the underlying pattern. They would not expect a surface product to substitute for it. Copper appears in the classical materia medica only as a mineral used in specific, limited ways, and nothing in the tradition anticipated this molecule. If you have a practitioner, slow healing or thinning hair is worth raising with them, because the pattern behind it is what they would treat.

Cautions For This Practice

Extra restraint

Everything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.

Injected or systemic GHK-Cu has no controlled human evidence of benefit and no established safety

Published GHK-Cu research in people is limited to topical and formulation contexts and small cosmetic or post-procedure use; the regenerative and protective actions summarized in reviews rest on cell, animal and gene-expression data. No controlled human trials establish benefit or safety for injected, subcutaneous or otherwise systemic GHK-Cu, which is distributed through grey-market and research-chemical channels without manufacturing oversight. This reflects an absence of human trials for systemic use, not a measured harm; unmonitored copper exposure and unverified product purity are the specific concerns.Pickart & Margolina, Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data

Do not inject it or take it to act through the body

Injected under the skin or into muscle, or taken to work systemically, GHK-Cu has no controlled human evidence of benefit and no established safety at those doses. It is sold through grey-market and research-chemical channels with no manufacturing oversight, so purity, dose and contamination are unknown. Extra copper in the body is not harmless, and the safe topical record does not carry over to injection.

Expect irritation to be possible on skin

Topical GHK-Cu is generally well tolerated. But any leave-on product can cause redness, stinging or an allergic contact reaction, and copper itself can sensitize some people. Introduce it alone, patch test on the inner forearm first, and stop if you get persistent redness, itching or swelling; do not push through it.

Keep it off open wounds and eyes unless a clinician directs it

Cosmetic serums are made for intact skin. Do not put a skin-care product into an open wound, a fresh surgical site, or the eyes on your own. Wound and post-procedure care belongs with the clinician managing it.

Be conservative in pregnancy and breastfeeding

There is little to no safety data on topical GHK-Cu in pregnancy or breastfeeding. Skin absorption of a low-concentration peptide is likely small. With no evidence either way, the cautious choice is to hold off on cosmetic actives for now, or to ask your clinician first.

Use it on top of proven care

Do not use a copper peptide in place of care that works. Thinning hair, a non-healing wound, or a changing mole needs a clinician.

Start slow, be smart, read the research, and consult a professional if you have any concerns. This is here to inform your choice, not make it for you.

Common Questions

Does GHK-Cu actually reduce wrinkles?

The mechanism is real; the one facial trial found no measured benefit. Put sunscreen and a retinoid first.

Can it regrow hair?

No good trial shows topical GHK-Cu growing hair in people; the one study often cited used AHK-Cu, a different peptide. For hair loss, minoxidil and finasteride have real human evidence and are the better place to start.

How does it compare with a retinoid or vitamin C?

Vitamin C paired with sunscreen has been studied far longer than copper peptides, and GHK-Cu sits below it on the strength of human data. Use it as an extra layer once sunscreen and a retinoid are in place.

Explore Related

Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.

Related evidence What topical tretinoin does for fine sun lines, rough texture, uneven color and acne, how it rebuilds collagen, how to use it without wrecking your skin, and why it is avoided in pregnancy.
Related evidence Acne is common and highly treatable. What clears it, in order: retinoids and benzoyl peroxide, hormonal options for women, isotretinoin for severe cases, and where diet actually fits.
Related evidence Eczema is a skin-barrier and immune condition. Moisturize heavily every day, treat flares promptly with a topical steroid, and turn to dupilumab or JAK tablets only when creams fail.
Related evidence Hair loss is several conditions, not one, and most is treatable caught early. What minoxidil, finasteride and JAK inhibitors do, why telogen effluvium regrows on its own, and why biotin rarely helps.
Related evidence Psoriasis is an immune-mediated disease, and modern drugs now nearly clear the skin. What topical treatment, UVB phototherapy and the biologics do, and why special diets and detoxes do not clear it.

All 9 sources on this page independently checked and cross-referenced.

Thomas Dehli, Founder & Editor, Sacred Lotus

Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 10, 2026.